Previous studies have reported that elevated ANGPTL4 serum concentrations were associated with high-grade tumors in women with localized breast cancer [37], and with hepatic metastatic risk in hepatocellular carcinoma [31]. Here, ANGPTL4 is linked to hepatocellular carcinoma.